Growth of home respiratory equipment from 2006 to 2019 and cost control by health policies - 29/11/22
, Amandine Baptiste d, e, Benjamin Granger d, e, Aurélie Villemain b, Raphaëlle Ohayon a, c, Claudio Rabec c, f, François Chabot b, c, Jésus Gonzalez-Bermejo a, c, gAbstract |
Background |
Home respiratory equipment (HRE) designed for the management of chronic respiratory failure includes oxygen therapy (O2), noninvasive ventilation (NIV) and mechanical insufflation-exsufflation (MI-E). The growth of the number of patients treated by HRE, the prevalence and the associated costs in France have not been determined.
Methods |
The French open access national health insurance aggregated data was used to estimate the evolution of theses parameters from 2006 to 2019.
Results |
The number of patients treated by HRE increased by 117% between 2006 and 2019, reaching a total of 245,896 patients (367/100,000). Prescriptions for O2, NIV, and MI-E increased by 88%, 189% and 162%, respectively. In 2019, 139,323 patients received long-term home O2 alone (208/100,000) with a 13% decrease for liquid O2 compared to a 44% increase for O2 concentrator. The number of patients treated by portable oxygen concentrator increased by 509% over the last 5 years. In 2019, 96,126 patients received NIV (144/100,000) and 97% of these patients were treated by NIV for less than 12 h/day. A total of 9,158 patients were treated by MI-E in 2019 (13.6/100,000). Despite the global increase in the number of patients, health costs decreased from 9% to 8% of total medical device spending in 2019 due to adjustment of health policies, such as a reduction of reimbursement rates.
Conclusion |
Our results highlighted the high rate of HRE prescription, but with cost control as a result of adapted health policies.
Le texte complet de cet article est disponible en PDF.Keywords : Home respiratory equipment, Chronic respiratory failure, Epidemiology, Noninvasive ventilation, Oxygen therapy
Plan
Vol 82
Article 100930- novembre 2022 Retour au numéro
Article précédent
- Clinical outcomes and lung ultrasound findings in COVID-19 follow up: Calm comes after the storm?
- Nikita Gurbani, Marco Acosta-Sorensen, David Díaz-Pérez, Juan Marco Figueira-Goncalves, Yolanda Ramallo-Fariña, José Luis Trujillo-Castilla
- Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort
- George Calcaianu, Samuel Degoul, Bénédicte Michau, Thibault Payen, Anthony Gschwend, Mathieu Fore, Carmen Iamandi, Hugues Morel, Jean-Philippe Oster, Acya Bizieux, Cécilia Nocent-Ejnaini, Cécile Carvallo, Stéphanie Romanet, François Goupil, Amélie Leurs, Marie-Germaine Legrand, Laurent Portel, Johanna Claustre, Mihaela Calcaianu, Didier Bresson, Didier Debieuvre
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?